Business context and reporting period
Quaker Chemical Corporation filed this Form 8-K on October 1, 2026, reporting entry into an amendment to its existing credit agreement. The filing reports a financing transaction, not quarterly operating results.
Key financial and debt terms
- The amendment establishes a new $550 million, seven-year senior secured U.S. dollar Term Loan B Facility. Proceeds are intended to repay the existing U.S. Term Loans in full; their aggregate principal balance was $0 as of the amendment’s effective date.
- The facility matures October 1, 2033. Quarterly amortization is 0.25% of the initial aggregate principal amount, with the remaining balance due at maturity.
- At the Company’s election, interest is Term SOFR plus 1.750% or Base Rate plus 0.750%. The filing does not provide a specific all-in borrowing rate.
- Mandatory prepayments include excess cash flow, certain asset-sale proceeds, certain debt-issuance proceeds, and certain extraordinary receipts, subject to specified thresholds, step-downs, reinvestment rights, and other conditions. Excess-cash-flow prepayments are subject to a $30 million annual threshold and leverage-based rates of 50%, 25%, or 0%.
- A 1.00% premium applies to certain prepayments or repricings arising from a Repricing Event within six months after October 1, 2026.
The 8-K does not provide revenue, profit, cash-flow, margin, total debt, cash, or liquidity figures, nor does it quantify the impact of the refinancing on those measures.
Material changes and outlook
The new facility replaces the existing U.S. Term Loans and adds a new senior secured term-loan class. JPMorgan Chase Bank, N.A. is administrative agent for the Term Loan B Facility; Bank of America, N.A. remains agent for the other specified credit facilities and serves as collateral and general administrative agent. The filing gives no earnings guidance or business outlook.
Risks, covenants, and other notable terms
- The facility is guaranteed by certain domestic subsidiaries and secured by first-priority liens on substantially all assets of the Company and subsidiary guarantors, subject to customary exclusions.
- The amendment includes customary affirmative and negative covenants, events of default, and restrictions on matters including debt, investments, acquisitions, dividends, and asset dispositions, subject to exceptions and baskets.
- The Term Loan B Facility is described as covenant-lite: a breach of financial maintenance covenants does not become an Event of Default for this facility unless Required Pro Rata Facilities Lenders have declared obligations under the Pro Rata Facilities immediately due and payable. Other events of default could accelerate obligations and terminate the credit agreement.
- The Company may seek incremental facilities or equivalent debt subject to stated capacity, leverage tests, and other conditions. Certain pari passu incremental term B loans incurred within six months are subject to a most-favored-nation rate provision.
- The full amendment was expected to be filed as an exhibit to the Company’s quarterly report for the quarter ended September 30, 2026. The filing text does not include the attached press release’s substantive contents.
Investor verification points
- Verify the final executed amendment and any omitted schedules when filed, including detailed definitions, exceptions, and covenant conditions.
- Confirm the amount of old U.S. Term Loans repaid and the new facility’s funded balance, fees, and all-in borrowing cost.
- Review subsequent disclosures for updated total debt, leverage, liquidity, and any effect on interest expense or cash flow.
- Monitor compliance with mandatory prepayment provisions, leverage thresholds, and the six-month repricing-premium period.